Possibia

1809743

Last Update Posted: 2013-11-13

Recruiting has ended

All Genders

accepted

18 Years-80 Years

100 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Regadenoson and Adenosine

The aim of the study is to test the accuracy of Regadenoson to induce maximal and steady state hyperemia as compared to central venous infusion of adenosine for assessing fractional flow reserve. (adenosine is considered to be the gold standard)and to investigate the time intervals of maximum hyperemia induced by centrally and peripherally administered Regadenoson.

Eligibility

Relevant conditions:

Coronary Artery Disease

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov